On the other hand, it was pointed out that EPO in co-therapy with carboplatin enhances vascularization and perfusion, improves the delivery of carboplatin in non-small cell lung cancer xenografts, and results in more pronounced apoptosis. The gene discussed is EPO; the disease is non-small cell lung carcinoma.